Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Institut Paoli-Calmettes
With
Novartis Pharmaceuticals
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
1. Patients included in the RosaLEE study.
2. Patients having read and signed the ICF relative to Trans-RosaLEE.
3. Tumour material: primary and/or metastatic tumour sample, either available as frozen and collected within 3 months before V0, or newly collected before ribociclib + ET treatment initiation.
Brain metastases and non-osteolytic bone metastases will be considered as non-collectable/biopsable.
4. Patient affiliated to the national "Social Security" regimen or beneficiary of this regimen.
You may not be if
1. Not enrolled in RosaLEE.
2. Brain metastasis and non-osteolytic bone metastases as only metastatic sites, if no available frozen tumour sample already collected within 3 months before V0.
3. Tumour material not collected before ribociclib + ET initiation.
4. Person subject to a legal protection measure (adult under guardianship, curatorship or safeguard of justice), or unable to give their consent.
Clareo Health | Trans-RosaLEE Study: a Biomarker-directed, Translational Study
